Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Psyence Group Inc (OP: PSYGF ) 0.0119 UNCHANGED Last Price Updated: 1:44 PM EST, Nov 4, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Psyence Group Inc Psychedelics Headlines: Anti-inflammatory Effects, Global Drug Survey, 'Synthetic Surprise,' UK's Harm Reduction Hub And More January 26, 2024 Discover the latest research on psychedelics, from anti-inflammatory effects to end-of-life therapy. New journal issue and online course available. Via Benzinga How To Finance A Psychedelics Business? Learn From These Four Companies April 04, 2023 Clearmind Medicine Announces Pricing of $3.5 Million Public Offering Via Benzinga Psyched: Australia As Psychedelics Hub, Advanced Scans Of Brain On DMT, New PAC For Congressional Influence, 9 States Advancing Bills & More March 27, 2023 Australia: Enveric, FSD Pharma, Psyence & Others Advance Businesses Via Benzinga Psychedelic Research Expands In Australia With Palliative Care Partnership & New MDMA Analog Portfolio March 21, 2023 Psyence Partners with iNGENū for Palliative Care Clinical Trial Via Benzinga Psychedelics Update: MDMA Export, 3D Farm, Recovery Center Reopens, Mushroom Extraction & E-Commerce January 24, 2023 Health Canada Oks Clinical-Grade MDMA Export To UK Life sciences psychedelics company PharmAla Biotech Holdings Inc. and its manufacturing partners received a Health Canada export permit for no less... Via Benzinga Psychedelics Travel: Clinical-Grade Magic Mushrooms Extract Exported From Southern Africa To UK January 20, 2023 Lifesciences psychedelics biotech Psyence Group Inc. (OTCQB: PSYGF) recently exported purified pharmaceutical-grade psilocybin mushroom extract from its licensed and certified production facility in... Via Benzinga 6 Psychedelics Companies Take Action: Here Are The Latest, Major Announcements January 10, 2023 Second week of 2023, and business is up and running. Let’s take a look at the announcements shared by some of the companies in the psychedelics space. Via Benzinga Psyched: First Ayahuasca Pill Created, Psychedelics Legalization Predicted, UK's Research Support And More December 19, 2022 Ayahuasca Pill Is Officially Here, Filament CEO Discusses Future Plans The first medical-grade drug candidate of the psychedelic ayahuasca is being developed. Via Benzinga Psyence, Revive Therapeutics Ink Private Placements: Capital To Support Drug Trials December 16, 2022 Life sciences biotech Psyence Group Inc. (OTCQB: PSYGF) has closed the second tranche of its previously announced private placement of up to $2.2 million (CA$3 million). Via Benzinga Psychedelics Company Filament Signs Licensing Deal With Psyence In US, UK And EU December 15, 2022 Filament Health Corp. (OTCQB: FLHLF) and Psyence Group Inc. (OTCQB: PSYGF) have inked a worldwide commercial licensing deal. Via Benzinga European Psychedelics Research Group Nabs $2M In Seed Funding As Clinical Research Picks Up Speed October 11, 2022 UK psychedelics clinical research organization Clerkenwell Health raised $2.047.710 (£2.1 million) in seed funding, bringing the total to date up to $2.437.750 (£2.5 million), all of which will be used... Via Benzinga International Magic Mushrooms: Where Are They Produced And Where Are They Headed? September 29, 2022 Psyence Group Inc. Via Benzinga Psyched: Magic Mushrooms Vs. Psychotherapy, Psilocybin For Frontline Health Workers & Protecting Peyote September 26, 2022 As a wave of news about psychedelics research and successful applications sweeps across the country and abroad, Psyched is back to wrap up the exciting movement of this rapidly evolving sector. Via Benzinga Magic Mushrooms Vs. Psychotherapy For Incurable Cancer Diagnosis Moves Forward In UK Clinical Trials September 19, 2022 UK's Medicines and Healthcare products Regulatory Agency (MHRA) approved Psyence Group Inc. Via Benzinga Psyched: Big Pharma's Sanofi Enters Psychedelics Space, DNA From 80 Psilocybe Mushrooms Published Online, Maine Psychedelics Bill Shelved April 25, 2022 Benzinga’s first-ever Psychedelics Capital Conference was a colossal success. Over 600 investors, policymakers, industry executives and thought leaders gathered at the Fontainebleau Hotel in Miami... Via Benzinga Psyence, Filament Strike Magic Mushroom Product Licensing Agreement: What You Need To Know April 19, 2022 Psyence Group (OTCQB: PSYGF) and Filament Health Corp. (OTCQB: FLHLF) announced the signing of a licensing agreement: Filament is to license its proprietary psilocybin derived drug, PEX010, and the... Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
